Inhalation Anesthesia Market Size, Share, and Trends 2025 to 2034

The global inhalation anesthesia market size was calculated at USD 2.14 billion in 2025 and is forecasted to reach around USD 3.61 billion by 2034, accelerating at a CAGR of 5.97% from 2025 to 2034. The North America inhalation anesthesia market size surpassed USD 830 million in 2024 and is expanding at a CAGR of 5.99% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

Last Updated : May 2025  |  Report Code : 1247  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Inhalation Anesthesia Market 

5.1. COVID-19 Landscape: Inhalation Anesthesia Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Inhalation Anesthesia Market, By Product Type

8.1. Inhalation Anesthesia Market Revenue and Volume, by Product Type

8.1.1 Apparatus

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Anesthetics

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Accessories

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Inhalation Anesthesia Market, By Application

9.1. Inhalation Anesthesia Market Revenue and Volume, by Application

9.1.1. Human Healthcare

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Veterinary Healthcare

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global Inhalation Anesthesia Market, By End user 

10.1. Inhalation Anesthesia Market Revenue and Volume, by End user

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Clinics

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Ambulatory Surgical Centres

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Others

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Inhalation Anesthesia Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product Type

11.1.2. Market Revenue and Volume Forecast, by Application

11.1.3. Market Revenue and Volume Forecast, by End user

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product Type

11.1.4.2. Market Revenue and Volume Forecast, by Application

11.1.4.3. Market Revenue and Volume Forecast, by End user

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product Type

11.1.5.2. Market Revenue and Volume Forecast, by Application

11.1.5.3. Market Revenue and Volume Forecast, by End user

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product Type

11.2.2. Market Revenue and Volume Forecast, by Application

11.2.3. Market Revenue and Volume Forecast, by End user

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product Type

11.2.4.2. Market Revenue and Volume Forecast, by Application

11.2.4.3. Market Revenue and Volume Forecast, by End user

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product Type

11.2.5.2. Market Revenue and Volume Forecast, by Application

11.2.5.3. Market Revenue and Volume Forecast, by End user

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product Type

11.2.6.2. Market Revenue and Volume Forecast, by Application

11.2.6.3. Market Revenue and Volume Forecast, by End user

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product Type

11.2.7.2. Market Revenue and Volume Forecast, by Application

11.2.7.3. Market Revenue and Volume Forecast, by End user

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product Type

11.3.2. Market Revenue and Volume Forecast, by Application

11.3.3. Market Revenue and Volume Forecast, by End user

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product Type

11.3.4.2. Market Revenue and Volume Forecast, by Application

11.3.4.3. Market Revenue and Volume Forecast, by End user

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product Type

11.3.5.2. Market Revenue and Volume Forecast, by Application

11.3.5.3. Market Revenue and Volume Forecast, by End user

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product Type

11.3.6.2. Market Revenue and Volume Forecast, by Application

11.3.6.3. Market Revenue and Volume Forecast, by End user

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product Type

11.3.7.2. Market Revenue and Volume Forecast, by Application

11.3.7.3. Market Revenue and Volume Forecast, by End user

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.2. Market Revenue and Volume Forecast, by Application

11.4.3. Market Revenue and Volume Forecast, by End user

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.4.2. Market Revenue and Volume Forecast, by Application

11.4.4.3. Market Revenue and Volume Forecast, by End user

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product Type

11.4.5.2. Market Revenue and Volume Forecast, by Application

11.4.5.3. Market Revenue and Volume Forecast, by End user

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product Type

11.4.6.2. Market Revenue and Volume Forecast, by Application

11.4.6.3. Market Revenue and Volume Forecast, by End user

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product Type

11.4.7.2. Market Revenue and Volume Forecast, by Application

11.4.7.3. Market Revenue and Volume Forecast, by End user

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.2. Market Revenue and Volume Forecast, by Application

11.5.3. Market Revenue and Volume Forecast, by End user

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product Type

11.5.4.2. Market Revenue and Volume Forecast, by Application

11.5.4.3. Market Revenue and Volume Forecast, by End user

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.5.2. Market Revenue and Volume Forecast, by Application

11.5.5.3. Market Revenue and Volume Forecast, by End user

Chapter 12. Company Profiles

12.1. Piramal Critical Care

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Baxter

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Midmark Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Halocarbon

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Hengrui Medicine

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Kent Scientific Corporation

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Merck KGaA

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. BOC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. AbbVie Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Raman & Weil Pvt. Ltd.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global inhalation anesthesia market size was valued USD 2.02 billion in 2024 and is predicted to reach USD 3.61 billion by 2034.

The global inhalation anesthesia market is expected to growing at a noteworthy CAGR of 5.97% over forecast period 2025 to 2034.

Growing numbers of surgical procedures across the globe, along with emergence of the trauma cases worldwide are some among the major factors driving growth of the global market. Additionally, increasing geriatric population, increasing cancer patient pool, rising cardiovascular, gastrointestinal, respiratory, neurological disorders are expected to propel growth of the target market in next 10 years.

Anesthetics product type segment is expected to account for the major share in the target market. The growth is attributed to growing adoption of the anesthetics in the various end use applications worldwide.

The main firms working in the global inhalation anesthesia industry across the globe Piramal Critical Care, Baxter, Midmark Corporation, Halocarbon, Hengrui Medicine, Kent Scientific Corporation, Merck KGaA, BOC, AbbVie Inc. Raman & Weil Pvt. Ltd.

Asia Pacific is probable to list the remarkable CAGR, on account of growing demand for the inhalation anesthesia in end use industry.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client